Up to 2022, successful seventeen marine-derived drugs have been clinically approved for markets for the treatment of numerous medical and life induced challenges, in addition to twenty other candidates, which are currently being investigated in different preclinical trials . Likely, such unique habitat presents thousands of new and novel compounds that are being disclosed each year from different marine organisms like sponges, soft corals, tunicates, algae, and microbes .